blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3801641

EP3801641 - COMPOSITIONS AND METHODS FOR THE MODULATION OF ADAPTIVE IMMUNITY [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  12.03.2021
Database last updated on 31.05.2024
FormerThe international publication has been made
Status updated on  14.12.2019
Most recent event   Tooltip13.04.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Locanabio, Inc.
3545 John Hopkins Court Suite 200
San Diego CA 92121 / US
[2021/15]
Inventor(s)01 / NELLES, David A.
7770 Regents Road
San Diego, California 92122 / US
02 / BATRA, Ranjan
7770 Regents Road
San Diego, California 92122 / US
03 / YEO, Eugene
7770 Regents Road
San Diego, California 92122 / US
 [2021/15]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2021/15]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date19814000.607.06.2019
[2021/15]
WO2019US36050
Priority number, dateUS201862682276P08.06.2018         Original published format: US 201862682276 P
[2021/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019236998
Date:12.12.2019
Language:EN
[2019/50]
Type: A1 Application with search report 
No.:EP3801641
Date:14.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 12.12.2019 takes the place of the publication of the European patent application.
[2021/15]
Search report(s)International search report - published on:US12.12.2019
(Supplementary) European search report - dispatched on:EP26.08.2022
ClassificationIPC:A61K48/00, C12N9/22, C12N15/62
[2021/15]
CPC:
C12N15/90 (EP,KR); C12N15/113 (KR); C12N15/11 (US);
A61K48/005 (US); C12N15/102 (KR); C12N15/1136 (EP,KR);
C12N15/1138 (EP,KR); C12N2310/20 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/15]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION VON ADAPTIVER IMMUNITÄT[2021/15]
English:COMPOSITIONS AND METHODS FOR THE MODULATION OF ADAPTIVE IMMUNITY[2021/15]
French:COMPOSITIONS ET PROCÉDÉS DE MODULATION DE L'IMMUNITÉ ADAPTATIVE[2021/15]
Entry into regional phase06.01.2021National basic fee paid 
06.01.2021Search fee paid 
06.01.2021Designation fee(s) paid 
06.01.2021Examination fee paid 
Examination procedure06.01.2021Examination requested  [2021/15]
21.03.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
14.06.2021Renewal fee patent year 03
31.03.2022Renewal fee patent year 04
31.03.2023Renewal fee patent year 05
12.04.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IY]  - OMAR O ABUDAYYEH ET AL, "RNA targeting with CRISPR-Cas13", NATURE, London, (20171004), vol. 550, no. 7675, doi:10.1038/nature24049, ISSN 0028-0836, pages 280 - 284, XP055529736 [I] 9-15 * figure 1g * [Y] 1-8

DOI:   http://dx.doi.org/10.1038/nature24049
 [XY]  - JIANGTAO REN ET AL, "Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition", CLINICAL CANCER RESEARCH, US, (20161104), vol. 23, no. 9, doi:10.1158/1078-0432.CCR-16-1300, ISSN 1078-0432, pages 2255 - 2266, XP055565027 [X] 1-7 * abstract * [Y] 1-8

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-16-1300
 [Y]  - DAVID A. NELLES ET AL, "Applications of Cas9 as an RNA-programmed RNA-binding protein", BIOESSAYS, GB, (20150416), vol. 37, no. 7, doi:10.1002/bies.201500001, ISSN 0265-9247, pages 732 - 739, XP055345194 [Y] 1-8 * page 736; figure 1 *

DOI:   http://dx.doi.org/10.1002/bies.201500001
 [Y]  - SHI C ET AL, "beta2-Microglobulin: emerging as a promising cancer therapeutic target", DRUG DISCOVERY TODAY, ELSEVIER, AMSTERDAM, NL, vol. 14, no. 1-2, doi:10.1016/J.DRUDIS.2008.11.001, ISSN 1359-6446, (20090101), pages 25 - 30, (20090101), XP025868046 [Y] 1-8 * page 28 *

DOI:   http://dx.doi.org/10.1016/j.drudis.2008.11.001
 [Y]  - WIEGMANN BETTINA ET AL, "Prevention of rejection of allogeneic endothelial cells in a biohybrid lung by silencing HLA-class I expression", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, (20140621), vol. 35, no. 28, doi:10.1016/J.BIOMATERIALS.2014.06.007, ISSN 0142-9612, pages 8123 - 8133, XP028861826 [Y] 1-8 * page 8124 *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2014.06.007
 [Y]  - LIANG CAIXIA ET AL, "RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats", JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, (20160503), vol. 297, doi:10.1016/J.JNEUROIM.2016.05.002, ISSN 0165-5728, pages 28 - 37, XP029631257 [Y] 1-8 * page 29 *

DOI:   http://dx.doi.org/10.1016/j.jneuroim.2016.05.002
 [Y]  - SILVANA KONERMANN ET AL, "Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors", CELL, Amsterdam NL, (20180419), vol. 173, no. 3, doi:10.1016/j.cell.2018.02.033, ISSN 0092-8674, pages 665 - 676, XP055529705 [Y] 1-8 * abstract *

DOI:   http://dx.doi.org/10.1016/j.cell.2018.02.033
International search[Y]WO2017091630  (UNIV CALIFORNIA [US], et al) [Y] 14, 25 * entire document *;
 [XY]WO2017093969  (NOVARTIS AG [CH], et al) [X] 1-13, 15 * entire document * [Y] 14, 16-30;
 [A]WO2018081806  (UNIV FLORIDA [US]) [A] 1-30* entire document *;
 [XP]WO2018170333  (BROAD INST INC [US], et al) [XP] 1-30 * entire document *;
 [Y]  - COX et al., "RNA editing with CRISPR-Cas13", Science, (20171124), vol. 358, no. 6366, pages 1019 - 1027, XP055491658 [Y] 16-30 * . entire document *

DOI:   http://dx.doi.org/10.1126/science.aaq0180
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.